47. Intraventricular chemotherapy and nonsmall cell lung carcinoma

Article type: Letter to Editor                                                                                    

Article title: Intraventricular chemotherapy and nonsmall cell lung carcinoma

 

Journal: Vascular Investigation and Therapy

Year: 2020

Authors: Jamir Pitton Rissardo, Ana Letícia Fornari Caprara           

E-mail: jamirrissardo@gmail.com

 

ABSTRACT

As Kaur et al. stated metastases to the choroid plexus, ventricles, pituitary gland, or leptomeninges are rare, and when encountered in clinical practice, the treatment is a tough decision. In this context, adenocarcinomas are the most common solid tumors to metastasize to the meninges. When lung cancer is analyzed, more than three-quarters of these metastases are related to adenocarcinoma histopathology. The development of new therapeutic options for the systemic treatment of nonsmall cell lung cancer is changing the landscape of this rapidly fatal clinical condition. Herein, we would like to discuss more leptomeningeal metastasis and intraventricular chemotherapy.

Keywords: Intraventricular, chemotherapy, nonsmall cell lung carcinoma


Full text available at:

https://www.vitonline.org/article.asp?issn=2589-9686;year=2019;volume=2;issue=4;spage=105;epage=106;aulast=Rissardo

 

DOI

10.4103/VIT.VIT_18_19

 

Citation

Rissardo JP, Caprara AL. Intraventricular chemotherapy and nonsmall cell lung carcinoma. Vasc Invest Ther 2019;2:105-6